Lycopene dietary intervention: a pilot study in patients with heart failure

Area of Science:

• Cardiology
• Nutrition Science
• Biochemistry

Background:

• Heart failure (HF) involves complex biochemical and biological mechanisms, with inflammation playing a key role in its pathophysiology.
• Antioxidants show potential in mitigating HF progression by inhibiting inflammatory processes.
• Lycopene, a potent antioxidant, is investigated for its anti-inflammatory effects in HF patients.

Purpose of the Study:

• To evaluate the impact of a dietary lycopene intervention on inflammation biomarkers in patients with heart failure.
• To assess changes in serum lycopene, uric acid, C-reactive protein (CRP), and b-type natriuretic peptide.

Main Methods:

• Forty participants diagnosed with heart failure were randomized into two groups: lycopene intervention and usual care.
• The intervention group consumed a daily 11.5 oz serving of V8 100% vegetable juice, providing 29.4 mg of lycopene, for 30 days.
• Serum samples were analyzed for lycopene, uric acid, CRP, and b-type natriuretic peptide levels.

Main Results:

• Plasma lycopene levels significantly increased in the intervention group compared to the usual care group.
• C-reactive protein (CRP) levels demonstrated a significant decrease in female participants within the intervention group (P = .04).
• Pre- to post-intervention CRP levels decreased from 5.9 ± 3.7 mg/dL to 4.5 ± 3.6 mg/dL in women, while men showed minimal change.

Conclusions:

• A 30-day dietary intervention with V8 juice, rich in antioxidants like lycopene, positively impacts CRP levels in female heart failure patients.
• These findings highlight the potential role of lycopene in managing inflammation associated with heart failure, particularly in women.
• Further research is warranted to explore the broader therapeutic applications of lycopene in cardiovascular health.